precision medicine

Abu Dhabi, UAE: The UAE healthcare system has established itself as a global leader in preventive medicine, driven by cutting-edge technology, genomic research, and AI-powered healthcare solutions. Speaking to the Emirates News Agency (WAM), Hasan Jasem Al Nowais, Managing Director and Group CEO of M42, highlighted the nation’s advancements underpinned by visionary leadership and collaborative innovation. Driving Healthcare Innovation Al Nowais credited the UAE’s leadership for fostering an ecosystem that integrates advanced hospitals, robotic technologies, genomic science, and artificial intelligence, enabling a shift from reactive treatment to proactive health management. He underscored M42’s collaboration with government entities to revolutionize healthcare by focusing on: Early detection of health risks through data-driven insights Delivering targeted treatments more efficiently Reducing healthcare costs while improving outcomes M42’s Vision for Preventive Care M42 is committed to shifting healthcare paradigms by prioritizing precision, preventive, and predictive medicine. The group also aims to enhance healthy ageing, promote general well-being, and transition to a more sustainable healthcare model. “For meaningful, lasting, and positive change that enhances human longevity worldwide, we must collectively focus on three pillars: precision, preventive, and predictive medicine,” Al Nowais stated, emphasizing the role of AI and genomic science in detecting diseases before symptoms arise. Innovative AI Solutions M42 has introduced several groundbreaking healthcare innovations: Med42: An open-source, large clinical language model AIRIS-TB: An AI-powered system capable of conducting 2,000 chest X-rays daily to combat tuberculosis—ten times the capacity of traditional methods AI in Endoscopy: Enhances the detection of abnormalities and early signs of cancer These technologies signify a leap in diagnostic efficiency and precision, paving the way for personalized care. Genomics and the UAE Genome Programme M42’s Omics Centre of Excellence is spearheading genomic research, including the UAE Genome Programme, which aims to advance precision medicine and proactive health management. These initiatives are crucial for identifying genetic predispositions to diseases, further strengthening the UAE’s position as a leader in genomics-driven preventive healthcare. Global Inspiration Al Nowais concluded by highlighting the UAE’s commitment to setting new global standards in healthcare. Through innovations in AI, genomic science, and cross-sector collaboration, the UAE is shaping a future where preventive medicine and sustainable healthcare become the norm, inspiring countries worldwide. Source: Business Standard Photo Credit: Business Standard